These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8118271)

  • 21. [Long-term follow-up of patients with borderline tumors of the ovaries].
    Adam R; Schmidt C; Di Paolo M; Tulusan AH
    Gynakol Rundsch; 1990; 30 Suppl 1():48-50. PubMed ID: 2079299
    [No Abstract]   [Full Text] [Related]  

  • 22. Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis.
    Roush GR; el-Naggar AK; Abdul-Karim FW
    Gynecol Oncol; 1995 Mar; 56(3):430-4. PubMed ID: 7705680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma.
    Yoon BS; Kim YT; Kim S; Lee CS; Kim JW; Kim JH; Kim SW; Cho NH
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):110-5. PubMed ID: 17157431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.
    Friedlander ML; Russell P; Taylor IW; Hedley DW; Tattersall MH
    Pathology; 1984 Jul; 16(3):301-6. PubMed ID: 6514398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometry of ovarian neoplasms.
    Bell DA
    Curr Top Pathol; 1992; 85():337-56. PubMed ID: 1628517
    [No Abstract]   [Full Text] [Related]  

  • 27. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in ovarian cancer.
    Tropé C
    Cancer Treat Res; 1998; 95():287-352. PubMed ID: 9619290
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma.
    Volm M; Brüggemann A; Günther M; Kleine W; Pfleiderer A; Vogt-Schaden M
    Cancer Res; 1985 Oct; 45(10):5180-5. PubMed ID: 4027994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of image analysis in ovarian cancer.
    Miller BE; Lavia LA; Horbelt DV
    Cancer; 1991 Mar; 67(5):1318-21. PubMed ID: 1991294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
    Volm M; Drings P; Kleine W; Mattern J
    Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic factors in patients with ovarian cancer].
    Kojs Z; Reinfuss M; Urbański K
    Ginekol Pol; 1992 Jan; 63(1):6-9. PubMed ID: 1304510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early stage ovarian carcinoma--diagnosis and treatment].
    Abeler VM; Tropé CG
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):476-8. PubMed ID: 10833940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
    Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endodermal sinus tumor of the ovary: a case series with flow cytometric DNA content analysis.
    Kelley JL; Naus GJ; Christopherson WA
    Gynecol Oncol; 1991 Jul; 42(1):34-8. PubMed ID: 1916507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters].
    Araya JC; Roa I; Wistuba I; Villaseca MA; Contreras E; Olcese A; Danton A; Watanabe H
    Rev Med Chil; 1994 Jun; 122(6):643-52. PubMed ID: 7732208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulosa cell tumor of the ovary. Histopathologic and flow cytometric analysis with clinical correlation.
    Suh KS; Silverberg SG; Rhame JG; Wilkinson DS
    Arch Pathol Lab Med; 1990 May; 114(5):496-501. PubMed ID: 2334259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic significance of flow cytophotometric studies in ovarian cancer].
    Volm M; Kleine W
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):456-9. PubMed ID: 3623048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DNA ploidy in epithelial ovarian cancer--an independent prognostic factor].
    Tropé CG; Abeler V; Baekelandt M; Kaern J
    Tidsskr Nor Laegeforen; 2000 Jan; 120(1):43-9. PubMed ID: 10815478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.